PetVivo Holdings Inc (PETV) - Total Liabilities
Based on the latest financial reports, PetVivo Holdings Inc (PETV) has total liabilities worth $3.16 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore PetVivo Holdings Inc operating cash flow efficiency to assess how effectively this company generates cash.
PetVivo Holdings Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how PetVivo Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of PetVivo Holdings Inc to evaluate the company's liquid asset resilience ratio.
PetVivo Holdings Inc Competitors by Total Liabilities
The table below lists competitors of PetVivo Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sprintex Ltd
AU:SIX
|
Australia | AU$7.37 Million |
|
Online Brands Nordic AB
ST:OBAB
|
Sweden | Skr156.80 Million |
|
DK&D Co.Ltd
KQ:263020
|
Korea | ₩33.55 Billion |
|
Dcon Products Public Company Limited
BK:DCON
|
Thailand | ฿1.10 Billion |
|
Pacgold Ltd
AU:PGO
|
Australia | AU$1.70 Million |
|
Bangkok Dec-Con Public Company Limited
BK:BKD
|
Thailand | ฿435.60 Million |
|
Thai Agro Energy Public Company Limited
BK:TAE
|
Thailand | ฿1.14 Billion |
|
Modular Medical Inc
NASDAQ:MODD
|
USA | $4.21 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down PetVivo Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see PetVivo Holdings Inc (PETV) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.41 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.85 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.46 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how PetVivo Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for PetVivo Holdings Inc (2011–2025)
The table below shows the annual total liabilities of PetVivo Holdings Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $5.12 Million | +110.76% |
| 2024-03-31 | $2.43 Million | +41.74% |
| 2023-03-31 | $1.71 Million | +18.97% |
| 2022-03-31 | $1.44 Million | -16.83% |
| 2021-03-31 | $1.73 Million | +11.13% |
| 2020-03-31 | $1.56 Million | +1.48% |
| 2019-03-31 | $1.54 Million | +7.33% |
| 2018-03-31 | $1.43 Million | +32.86% |
| 2017-03-31 | $1.08 Million | -27.16% |
| 2016-03-31 | $1.48 Million | +145.83% |
| 2015-03-31 | $601.61K | +25.56% |
| 2014-03-31 | $479.15K | +86.83% |
| 2013-03-31 | $256.47K | +43.30% |
| 2012-03-31 | $178.97K | +127.33% |
| 2011-03-31 | $78.73K | -- |
About PetVivo Holdings Inc
PetVivo Holdings, Inc., a biomedical device company, manufactures, commercializes, and licenses medical devices and therapeutics for animals in the United States. The company's lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. It also provides therapeutic devices for … Read more